{"id":"W2900733038","doi":"10.1182/blood-2018-99-118344","title":"Mosunetuzumab, a Full-Length Bispecific CD20/CD3 Antibody, Displays Clinical Activity in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NHL): Interim Safety and Efficacy Results from a Phase 1 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Tolerability; Mantle cell lymphoma; Internal medicine; Follicular lymphoma; CD20; Lymphoma; Gastroenterology; Rituximab; Refractory (planetary science); Adverse effect; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001452934,0.0005972699,0.0007211974,0.0002210846,0.000324451,0.0005596048,0.0004130331,0.0006203726,0.001552838],"category_scores_gemma":[0.0004722918,0.0002050026,0.0004056593,0.0001970548,0.0003215217,0.0003972436,0.0001310759,0.001334986,0.0004097926],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005558652,"about_ca_system_score_gemma":0.0006465221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00062842,"about_ca_topic_score_gemma":0.001811367,"domain_scores_codex":[0.9997124,0.000135683,0.00001957229,0.00004072968,0.00003810217,0.00005348191],"domain_scores_gemma":[0.9996448,0.00007468864,0.00008081214,0.00002662217,0.00004000625,0.0001330895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1984919,0.04134108,0.02837102,0.0008126993,0.001205526,0.0005887601,0.0004023823,0.003114545,0.4754059,0.0002789892,0.006020594,0.2439666],"study_design_scores_gemma":[0.1328592,0.654703,0.1114406,0.00007809805,0.001136518,0.001566905,0.00009703307,0.003217349,0.08472481,0.0002745332,0.009849535,0.00005243385],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952027,0.00178535,0.0004662094,0.0001481182,0.00001708417,0.0005141317,0.000489796,0.00006166277,0.001314931],"genre_scores_gemma":[0.9953879,0.0007722969,0.0008902071,0.0002364443,0.00004592154,0.0003772044,0.001387417,0.00001813604,0.0008845131],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001552838,"threshold_uncertainty_score":0.007683933,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04516121939774342,"score_gpt":0.3896615740049443,"score_spread":0.3445003546072009,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}